Neogenomics (NEO) Receivables - Other (2017 - 2024)
Historic Receivables - Other for Neogenomics (NEO) over the last 8 years, with Q4 2024 value amounting to $100000.0.
- Neogenomics' Receivables - Other rose 17027.03% to $100000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $100000.0, marking a year-over-year increase of 17027.03%. This contributed to the annual value of $100000.0 for FY2024, which is 17027.03% up from last year.
- Per Neogenomics' latest filing, its Receivables - Other stood at $100000.0 for Q4 2024, which was up 17027.03% from $236000.0 recorded in Q1 2024.
- In the past 5 years, Neogenomics' Receivables - Other ranged from a high of $2.9 million in Q3 2022 and a low of $37000.0 during Q4 2023
- Its 5-year average for Receivables - Other is $1.5 million, with a median of $1.9 million in 2020.
- Per our database at Business Quant, Neogenomics' Receivables - Other tumbled by 9808.19% in 2023 and then skyrocketed by 17027.03% in 2024.
- Quarter analysis of 5 years shows Neogenomics' Receivables - Other stood at $1.9 million in 2020, then increased by 2.12% to $2.0 million in 2021, then dropped by 2.28% to $1.9 million in 2022, then tumbled by 98.08% to $37000.0 in 2023, then soared by 170.27% to $100000.0 in 2024.
- Its Receivables - Other was $100000.0 in Q4 2024, compared to $236000.0 in Q1 2024 and $37000.0 in Q4 2023.